BOCA RATON, FL--(Marketwire - October 09, 2007) - Vicor Technologies, Inc. (OTCBB: VCRT), a development-stage company developing the PD2i Cardiac Analyzer, a patented device utilized in risk stratification of patients for Sudden Cardiac Death (SCD), is pleased to announce the issuance of its fourth patent entitled "Method and system for detecting and/or predicting cerebral disorders."
